These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 10926384)

  • 21. [Inhalation of high-doses of ipratropium bromide (Atrovent) does not cause any changes in systemic or pulmonary hemodynamics].
    Král B; Gregor J; Parízek P; Pudil R; Jílková V
    Cas Lek Cesk; 2000 Feb; 139(2):49-50. PubMed ID: 10802931
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bronchodilating effects of combined therapy with clinical dosages of ipratropium bromide and salbutamol for stable COPD.
    Ingram RH
    Chest; 1996 Jan; 109(1):293. PubMed ID: 8549206
    [No Abstract]   [Full Text] [Related]  

  • 23. Selective muscarinic antagonists as bronchodilators.
    Doods HN
    Agents Actions Suppl; 1991; 34():117-30. PubMed ID: 1793059
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tiotropium bromide (Ba 679 BR), a novel long-acting muscarinic antagonist for the treatment of obstructive airways disease.
    Barnes PJ; Belvisi MG; Mak JC; Haddad EB; O'Connor B
    Life Sci; 1995; 56(11-12):853-9. PubMed ID: 10188785
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ipratropium decreases airway size in dogs by preferential M2 muscarinic receptor blockade in vivo.
    Groeben H; Brown RH
    Anesthesiology; 1996 Oct; 85(4):867-73. PubMed ID: 8873558
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quality of life measurements and bronchodilator responsiveness in prescribing nebulizer therapy in COPD.
    Brophy C; Kastelik J; Gardiner E; Greenstone M
    Chron Respir Dis; 2008; 5(1):13-8. PubMed ID: 18303097
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of inhaled anticholinergic agents in obstructive airway disease.
    Restrepo RD
    Respir Care; 2007 Jul; 52(7):833-51. PubMed ID: 17594728
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antimuscarinic treatment for lung diseases from research to clinical practice.
    Disse B
    Life Sci; 2001 Apr; 68(22-23):2557-64. PubMed ID: 11392626
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Tiotropium (Spiriva) - a long-acting inhaled anticholinergic for the treatment of chronic obstructive pulmonary disease (COPD)].
    Beeh KM; Welte T; Buhl R
    Pneumologie; 2003 Sep; 57(9):519-25. PubMed ID: 13680472
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Milestones in inhalation therapy of airway diseases].
    Wettengel R
    Med Klin (Munich); 2002 Dec; 97 Suppl 2():7-11. PubMed ID: 12593175
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of patients hospitalized for exacerbations of chronic obstructive pulmonary disease: comparison of an oral/metered-dose inhaler regimen and an intravenous/nebulizer regimen.
    Shortall SP; Blum J; Oldenburg FA; Rodgerson L; Branscombe JM; Harrow EM
    Respir Care; 2002 Feb; 47(2):154-8. PubMed ID: 11812271
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [COPD treatment by drugs].
    Nafti S
    Rev Mal Respir; 2006 Sep; 23(4 Pt 2):10S58-10S60. PubMed ID: 17127967
    [No Abstract]   [Full Text] [Related]  

  • 33. Apples and oranges : flaws and guffaws.
    Petty TL
    Chest; 1999 Oct; 116(4):1137-8. PubMed ID: 10531190
    [No Abstract]   [Full Text] [Related]  

  • 34. Characterization of aclidinium bromide, a novel inhaled muscarinic antagonist, with long duration of action and a favorable pharmacological profile.
    Gavaldà A; Miralpeix M; Ramos I; Otal R; Carreño C; Viñals M; Doménech T; Carcasona C; Reyes B; Vilella D; Gras J; Cortijo J; Morcillo E; Llenas J; Ryder H; Beleta J
    J Pharmacol Exp Ther; 2009 Nov; 331(2):740-51. PubMed ID: 19710368
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anticholinergics in acute bronchial asthma.
    Holgate ST
    Postgrad Med J; 1987; 63 Suppl 1(743):35-9. PubMed ID: 2962072
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An international perspective on anticholinergic therapy.
    Chapman KR
    Am J Med; 1996 Jan; 100(1A):2S-4S. PubMed ID: 8610714
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Tiotropium as new quality medication in the COPD management].
    Lubiński W; Płusa T
    Pol Merkur Lekarski; 2006 Jan; 20(115):5-7. PubMed ID: 16617725
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anticholinergic agents in asthma and COPD.
    Gross NJ
    Eur J Pharmacol; 2006 Mar; 533(1-3):36-9. PubMed ID: 16488410
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bronchodilator activity of the selective muscarinic antagonist revatropate in horses with heaves.
    McGorum BC; Nicholas DR; Foster AP; Shaw DJ; Pirie RS
    Vet J; 2013 Jan; 195(1):80-5. PubMed ID: 22850354
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cholinergic pathways in the lungs and anticholinergic therapy for chronic obstructive pulmonary disease.
    Belmonte KE
    Proc Am Thorac Soc; 2005; 2(4):297-304; discussion 311-2. PubMed ID: 16267352
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.